1GH5 | pdb_00001gh5

ANTIFUNGAL PROTEIN FROM STREPTOMYCES TENDAE TU901, NMR AVERAGE STRUCTURE

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	0.5-0.8 mM AFP1 [U-99% 15N; U-10% 13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	91.7% H2O. 8.3% D2O.	0.32 M	8.0	ambient	293
2	3D_15N-separated_NOESY	0.5-0.8 mM AFP1 [U-99% 15N; U-10% 13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	91.7% H2O. 8.3% D2O.	0.32 M	8.0	ambient	293
3	HNHA	0.5-0.8 mM AFP1 [U-99% 15N; U-10% 13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	91.7% H2O. 8.3% D2O.	0.32 M	8.0	ambient	293
4	HNHB	0.5-0.8 mM AFP1 [U-99% 15N; U-10% 13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	91.7% H2O. 8.3% D2O.	0.32 M	8.0	ambient	293
5	4D_13C-separated_NOESY	0.5-0.8 mM AFP1 [U-99% 15N; U-13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	100% D2O	0.32 M	8.0	ambient	293
6	HN(CO)CG_arom/HNCG_arom	0.5-0.8 mM AFP1 [U-99% 15N; U-13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	91.7% H2O. 8.3% D2O.	0.32 M	8.0	ambient	293
7	2D NOESY	0.5-0.8 mM AFP1 [U-99% 15N; U-10% 13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	91.7% H2O. 8.3% D2O.	0.32 M	8.0	ambient	277
8	2D NOESY	0.5-0.8 mM AFP1 [U-99% 15N; U-10% 13C] 20 mM phosphate, pH 8.0. 0.1 M NaCl. 0.02 mM EDTA. 0.01% NaN3.	100% D2O	0.32 M	8.0	ambient	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	500
2	Bruker	DMX	600
3	Bruker	DMX	750
4	Bruker	DRX	800

NMR Refinement
Method	Details	Software
Torsion angle dynamics with DYANA.		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria
Conformers Calculated Total Number
Conformers Submitted Total Number	1

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe	X.X	Delaglio
2	data analysis	XwinNMR	4.1.1	Johnson
3	structure solution	DYANA	1.5	Guentert
4	refinement	DYANA	1.5	Guentert

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.